⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4861649 | 0.84 | — | — | |
| SCHEMBL13835607 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL15192075 | 0.80 | — | — | |
| SCHEMBL14699785 | 0.76 | — | — | |
| SCHEMBL767920 | 0.76 | — | — | |
| SCHEMBL5422549 | 0.76 | — | — | |
| SCHEMBL6484885 | 0.76 | — | — | |
| SCHEMBL13836325 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL767923 | 0.74 | CHRNA7 (0.32) | — | |
| Hydrochloric Acid SCHEMBL5428520 | 0.74 | CHRNA7 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130081999-A1 | Bridged Macrocyclic Module Compositions | WHITEFORD JEFFERY A (US) | 2013-04-04 | — | — | US | claimed |
| US-20100152438-A1 | AMPHIPHILIC MOLECULAR MODULES AND CONSTRUCTS BASED THEREON | COVALENT PARTNERS LLC | 2010-06-17 | — | — | US | claimed |
| US-20080290034-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2008-11-27 | — | — | US | claimed |
| US-20060270846-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC (US) | 2006-11-30 | — | — | US | claimed |
| US-20060128680-A1 | Macrocyclic module compositions | KRIESEL JOSH | 2006-06-15 | — | — | US | claimed |
| US-20050154199-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2005-07-14 | — | — | US | claimed |
| EP-1480635-A4 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-06-29 | — | — | EP | claimed |
| EP-1480635-A2 | MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2004-12-01 | — | — | EP | claimed |
| US-20040034223-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC. | 2004-02-19 | — | — | US | claimed |
| US-20030199688-A1 | Macrocyclic module compositions | COVALENT PARTNERS, LLC | 2003-10-23 | — | — | US | claimed |
| WO-2003066646-A2 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS, LLC (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2023118195-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2022258637-A1 | TRISLINKER-CONJUGATED DIMERIC LABELLING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM | Atoms for Cure GmbH (DE) | 2022-12-15 | — | — | WO | disclosed |
| EP-3281933-B1 | (METH)ACRYLATE MANUFACTURING METHOD | TOAGOSEI CO LTD (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10619058-B2 | Curable composition | TOAGOSEI CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-5091383-A | SUBSTITUTED BRIDGED DIAZABICYCLOALKYL QUINOLONE CARBOXYLIC ACIDS | PFIZER INC. (US) | 1992-02-25 | — | — | US | disclosed |
| EP-0215650-B1 | SUBSTITUTED BRIDGED-DIAZABICYCLOALKYL QUINOLONE CARBOXYLIC ACIDS | PFIZER INC. (US) | 1992-01-29 | — | — | EP | disclosed |
| US-4861779-A | Anti-bacterial substituted bridged-diazabicycloalkyl quinolone carboxylic acids | PFIZER INC. (US) | 1989-08-29 | — | — | US | disclosed |
| US-4775668-A | Substituted bridged-diazabicycloalkyl quinolone carboxylic acids and anti-bacterial use thereof | PFIZER INC. (US) | 1988-10-04 | — | — | US | disclosed |
| EP-0215650-A2 | Substituted bridged-diazabicycloalkyl quinolone carboxylic acids | PFIZER INC. (US) | 1987-03-25 | — | — | EP | disclosed |